REVERAGEN Trademark

Trademark Overview

On Tuesday, November 8, 2011, a trademark application was filed for REVERAGEN with the United States Patent and Trademark Office. The USPTO has given the REVERAGEN trademark a serial number of 85466817. The federal status of this trademark filing is ABANDONED - EXPRESS as of Friday, August 29, 2014. This trademark is owned by Reveragen BioPharma, Inc. The REVERAGEN trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Therapeutic pharmaceutical for the treatment of neuromuscular disease

Pharmaceutical drug development services
reveragen

General Information

Serial Number85466817
Word MarkREVERAGEN
Filing DateTuesday, November 8, 2011
Status601 - ABANDONED - EXPRESS
Status DateFriday, August 29, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, July 3, 2012

Trademark Statements

Indication of Colors claimedThe color(s) Black and Red is/are claimed as a feature of the mark.
Description of MarkThe mark consists of the word "REVERAGEN" in black letters with a red "V" and an initial capital letter "R" and a capital "G" and a stylized "N" for the final "N"
Goods and ServicesTherapeutic pharmaceutical for the treatment of neuromuscular disease
Goods and ServicesPharmaceutical drug development services

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 14, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, November 14, 2011
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameReveragen BioPharma, Inc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
Addressrockville, MD 20910
Party NameReveragen BioPharma, Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
Addressrockville, MD 20910

Trademark Events

Event DateEvent Description
Friday, August 29, 2014ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT
Friday, August 29, 2014ABANDONMENT - EXPRESS MAILED
Thursday, August 28, 2014TEAS EXPRESS ABANDONMENT RECEIVED
Wednesday, March 12, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 11, 2014EXTENSION 3 GRANTED
Wednesday, February 26, 2014EXTENSION 3 FILED
Wednesday, February 26, 2014TEAS EXTENSION RECEIVED
Wednesday, August 7, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 6, 2013EXTENSION 2 GRANTED
Wednesday, July 31, 2013EXTENSION 2 FILED
Wednesday, July 31, 2013TEAS EXTENSION RECEIVED
Wednesday, May 15, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 14, 2013EXTENSION 1 GRANTED
Thursday, February 28, 2013EXTENSION 1 FILED
Friday, May 10, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, April 19, 2013NOTICE OF REVIVAL - E-MAILED
Friday, April 19, 2013EXTENSION RECEIVED WITH TEAS PETITION
Friday, April 19, 2013PETITION TO REVIVE-GRANTED
Friday, April 19, 2013TEAS PETITION TO REVIVE RECEIVED
Monday, April 1, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, April 1, 2013ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 28, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 3, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 3, 2012PUBLISHED FOR OPPOSITION
Wednesday, June 13, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 29, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, May 22, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 21, 2012EXAMINER'S AMENDMENT ENTERED
Monday, May 21, 2012NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, May 21, 2012EXAMINERS AMENDMENT E-MAILED
Monday, May 21, 2012EXAMINERS AMENDMENT -WRITTEN
Monday, May 21, 2012PREVIOUS ALLOWANCE COUNT WITHDRAWN
Wednesday, March 21, 2012WITHDRAWN FROM PUB OTQR REQUEST
Tuesday, March 13, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, March 12, 2012ASSIGNED TO LIE
Saturday, February 25, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, February 25, 2012ASSIGNED TO EXAMINER
Monday, November 14, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, November 11, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

reveragen pharmaceutical development services drug neuromuscular treatment therapeutic disease